Elevation Oncology, Inc. (ELEV) Misses Q1 EPS by 4c

Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• IP Strategy Holdings receives Nasdaq noncompliance notice over late 10-Q
• Honda and Nissan to jointly develop vehicle sofware, Nikkei reports